Table 3.
Risk factors associated with thromboembolic events (PREvention oF thromboembolic events - European Registry in Atrial Fibrillation derivation cohort)
Variable | OR | 95% CI | P value | Score |
Abnormal liver function* | 2.86 | 1.24 to 6.63 | 0.0141 | 2 |
Labile INR† | 2.83 | 1.83 to 4.38 | <0.0001 | 2 |
Drugs‡ | 2.41 | 1.58 to 3.69 | <0.0001 | 1 |
Prior stroke/TIA/thromboembolic event | 2.79 | 1.81 to 4.28 | <0.0001 | 2 |
Heart failure | 2.20 | 1.45 to 3.33 | 0.0002 | 1 |
Age ≥75 years | 1.53 | 1.00 to 2.33 | 0.0482 | 1 |
*Presence of cirrhosis, elevated liver transaminases or alkaline phosphatase >3 times above the upper limit of normal (ULN), or bilirubin >2 times above the ULN.
†<60% time in therapeutic range.
‡Antiplatelet agents or non-steroidal anti-inflammatory drugs.
INR, international normalised ratio; TIA, transient ischaemic attack.